Global In Vitro Fertilization Market by Instrument (Disposable Devices, Culture Media), by Type (Frozen Nondonor, Fresh Donor) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

In vitro fertilization is a global market that was worth USD 14.2 billion in 2020. It is expected to increase at a compound annual rate (CAGR of 6.5%) between 2021 and 2028. The market's growth is driven by rising reprotourism and increasing instances of male and female fertility. Globally, infertility is a major concern. The American Pregnancy Association states that male fertility accounts to 30% of all infertility cases. It contributes approximately one-fifth to infertility cases. Market growth will be supported by the increasing dependence on fertility treatments. The availability of funds is driving a rise in in vitro fertilization (IVF).

The Ontario government announced in December 2016 that it would fund IVF treatment for 5,000 women with a fertility program worth USD 50 million. The Singapore government also offers 75% co-funding of various ART procedures such as IVF, Gamete Intrafallopian Transfers (GIFT) and Intracytoplasmic Sperm Injections (ICSI). The Centers for Disease Control and Prevention reported in January 2015 that ICSI use has increased from 36.4% 1996 to around 76.2% 2012.

Techniques such as Testicular Sperm Extraction and TESE are being used to increase IVF success rates. An Australian scientist created an Artificial Intelligence tool, called Ivy, to identify the embryo that has the highest chance of becoming pregnant. These technologies increase the success rate for IVF pregnancies.

In vitro fertilization market impact of COVID-19: 22.4% decrease from 2019 to 2020

The COVID-19 pandemic caused fertility treatments to be suspended. This affected women psychologically and their treatments were canceled. A study by the American Society for Reproductive Medicine found that 62% of participants wanted to start treatment in October 2020 after the COVID-19 restrictions were removed. With certain guidelines, treatment centers can now resume their treatments. The Human Fertilization & Embryology Authority allowed treatment to resume in June 2020. Individuals infected by COVID-19 must wait 28 days after their recovery before initiating treatment.

Instrument Insights

In vitro fertilization instruments include culture media, capital equipment and disposable IVF devices. In 2020, the market was dominated by culture media with a 41% revenue share. The market's growth can be attributed to factors such as increased funding and research to improve culture media. To meet regulatory and sterility requirements, disposable devices will likely see the fastest growth in the future as the industry introduces disposable devices such as slides and chambers.

CrossBay Medical Inc. was approved by the FDA in May 2017 for its CrossBay IVF Embryo Transfer set. It has been approved for commercialization in Europe and China. These developments will increase disposable IVF devices' adoption. Recent innovations include disposable slides for sperm count, an imaging-based tracking system that isolates the best motile and disposable microchips.

Type Insights

In 2020, the global market was led by the frozen non-donor segment. This segment was responsible for more than 47% of the total revenue in 2020. In 2020, the second highest revenue share was attributed to the fresh non-donor segment. This segment is a result of the higher success rate at the first attempt.

The procedure is able to be done even in complex cases. This segment will also witness the fastest CAGR between 2021 and 2028. This type of IVF can be used for patients with Ovarian Hyperstimulation syndrome (OHSS). The global IVF market is segmented by type into fresh donor, frozen donor, fresh donor and frozen donor.

End-use Insights

In 2020, the fertility clinics market accounted for 79% of the total global market revenue. This segment will likely retain its dominant market position through the forecast period, growing at the fastest CAGR between 2021 and 2028. The number of fertility centers and clinics is on the rise due to increased demand for ART treatments. The growth of fertility clinics is expected to be driven by factors such as cost-effectiveness, accessibility of specialists, minimal or no chance of Hospital-Acquired Infections. Hospitals can also perform IVF treatments.

Many multispecialty hospitals offer IVF and infertility treatment. Hospitals for infertility treatment are more popular due to their accessibility and greater availability. Hospitals offer IVF treatments that are typically more expensive than those offered by fertility clinics. Highly skilled staff and physicians are required for IVF treatment. It is not a good idea to have IVF staff dedicated to hospitals. Because hospitals are a small segment of the overall market, they have high costs for training, employment, and remuneration.

Regional Insights

With a more than 37% revenue share in 2020, Europe was the dominant market. The growth of the regional market will be driven by factors such as the rise in medical tourism and legal changes related to IVF techniques. A growing number of Americans are visiting the Czech Republic to receive IVF treatments at lower prices. According to an ESHRE factsheet, January 2017 saw some reimbursement for ART in nearly all EU member countries (except Lithuania and Ireland).

From 2021 to 2028, the market in Asia Pacific will experience the highest CAGR. Due to awareness campaigns, changes in regulatory landscapes, and fertility tourism, the demand for IVF treatment in Asia Pacific is expected to rise.

Market Share Insights & Key Companies

Market players have adopted key strategies such as geographic expansion, mergers, product innovation & commercialization. In July 2019, Prime Tech and Vitrolife entered into a partnership agreement to market and design the Piezo technique for improved Intracytoplasmic Sperm Injections (ICSI) in human IVF worldwide, except for Thailand, Japan and Malaysia. The following are some of the major players in the global market for in vitro fertilization:

• OvaScience

• EMD Serono, Inc.

• Vitrolife AB

• Irvine Scientific

• Cook Medical, Inc.

• Cooper Surgical, Inc.

• Genea Biomedx

• Thermo Fisher Scientific, Inc.

• Progyny, Inc.

• Boston IVF

Up Market Research published a new report titled “In Vitro Fertilization Market research report which is segmented by Instrument (Disposable Devices, Culture Media), by Type (Frozen Nondonor, Fresh Donor), By Players/Companies Boston IVF, Genea Biomedx, Cooper Surgical Inc, Vitrolife AB, Progyny Inc, Irvine Scientific, EMD Serono Inc, Cook Medical Inc, Thermo Fisher Scientific Inc, OvaScience”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global In Vitro Fertilization Market Report Segments:

The market is segmented by Instrument (Disposable Devices, Culture Media), by Type (Frozen Nondonor, Fresh Donor).

In Vitro Fertilization Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the In Vitro Fertilization Market

Overview of the regional outlook of the In Vitro Fertilization Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The In Vitro Fertilization Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of In Vitro Fertilization Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Disposable Devices

                2. Culture Media

                1. Frozen Nondonor

                2. Fresh Donor

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the In Vitro Fertilization Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the In Vitro Fertilization Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.